Adherence and Reactogenicity to Vaccines against SARS-COV-2 in 285 Patients with Neuropathy: A Multicentric Study.

Salvatore Iacono Vincenzo Di StefanoPaolo AlongeClaudia VinciguerraGiammarco Milella Francesca CaputoPiergiorgio LasorellaGabriele NetoAntonia Pignolo Angelo Torrente Antonino Lupica Paola AjdinajAlberto FirenzeStefano TozzaFiore ManganelliAntonio Di MuzioGiuseppe PiscosquitoFilippo Brighina

Published in: Brain sciences (2022)

< 0.05). (4) Conclusions: Patients with neuropathy showed a high level of adherence to COVID-19 vaccination. Safety of vaccines in patients with neuropathies was comparable to the general population and it was more favorable in those with inflammatory neuropathy.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
oxidative stress
type diabetes
glycemic control
metabolic syndrome
adipose tissue
weight loss